Prospective Cohort Study of Pre- and Postdiagnosis Physical Activity and Endometrial Cancer Survival
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial We conducted a prospective cohort study in Alberta, Canada, of 425 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback